[Urinary retention following the use of beta-stimulating agents in obstetrics: physiopathological considerations and description of a case].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D009921:Metaproterenol / Q000009:adverse effects*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011433:Propranolol / Q000627:therapeutic use; D014555:Urination Disorders / Q000139:chemically induced* / Q000188:drug therapy
D000318:Adrenergic beta-Agonists; D009921:Metaproterenol; D011433:Propranolol
Ritenzione urinaria secondaria all'impiego di beta-stimolanti in ostetricia: considerazioni fisiopatologiche e descrizione di un caso clinico.